Volta Therapeutics

Gene Mediated Cell Therapies are cells from a patient or donor that are genetically engineered to create a therapeutic response against the patients disease The current manufacturing processes for engineering cell therapies are constrained to clean room suites and scale-out production models following Good Manufacturing Practices (GMPs). This causes large infrastructure demands and more GMP suites to accommodate more patients in need At Volta, we are creating an automated, closed system cell therapy manufacturing technology that can bring the GMP suites directly to the clinic. Our mission is to provide Capacity, Automation, and customization through continuous manufacturing devices to facilitate streamlined GMP cell therapy manufacturing